Mild moxibustion for Irritable Bowel Syndrome with Diarrhea (IBS-D): A randomized controlled trial

肠易激综合征 医学 艾灸 腹泻 针灸科 随机对照试验 安慰剂 腹痛 内科学 中医药 传统医学 胃肠病学 替代医学 病理
作者
Zhaoqin Wang,Manwen Xu,Zheng Shi,Chunhui Bao,Huirong Liu,Cili Zhou,Yilu Yan,Chunye Wang,Guona Li,Wei Zhang,Gao An-qi,Huangan Wu
出处
期刊:Journal of Ethnopharmacology [Elsevier]
卷期号:289: 115064-115064 被引量:21
标识
DOI:10.1016/j.jep.2022.115064
摘要

Moxibustion therapy is a traditional Chinese medicine external treatment method, which involves crushing dried herb Artemisia argyi H. Lév. & Vanio and rolling it into a long cigarette-like strip, igniting it and using its warmth to stimulate specific acupuncture points for a certain period of time. It is often used in Asia to treat various diseases, especially abdominal pain. Clinical reports suggest that acupuncture and moxibustion are the effective treatment for Irritable Bowel Syndrome with Diarrhea (IBS-D). However, there is no placebo-controlled study to prove its safety and efficacy. To evaluate the effects of mild moxibustion (MM) for the treatment of irritable bowel syndrome with diarrhea (IBS-D) through comparisons with those of placebo moxibustion. This was a single-site, randomized controlled trial was conducted at Shanghai Research Institute of Acupuncture and Meridian in China and enrolled 76 participants who met the Rome IV diagnostic criteria for IBS-D between May 2017 and December 2019. 76 participants were randomized to either mild moxibustion (MM) or placebo moxibustion group (PM) in a 1:1 ratio. 18 sessions of MM or PM were implemented over the course of 6 weeks (3 times per week). The primary outcome was adequate relief after 6 weeks of treatment. Of 76 patients with IBS-D who were randomized (38 in the MM group and 38 in the PM group) were included in the intention-to-treat (ITT) analysis set. After treatment at week 6, the response rate was significantly higher in the MM group than the PM group (81.58% vs. 36.84%) with an estimated difference of 44.74 (95% CI, 23.46 to 66.02, P < 0.001). No participant reported severe adverse effects. The findings suggest that mild moxibustion may be more effective than placebo moxibustion for the treatment of IBS-D, with effects lasting up to 12 weeks. ChiCTR, ChiCTR2100046852. Registered 29 May 2021 - Retrospectively registered, URL: http://www.chictr.org.cn/showproj.aspx?proj=127000.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
烟花应助miller采纳,获得10
刚刚
刚刚
1秒前
科研通AI2S应助生动的芝采纳,获得10
1秒前
任性的傲柏完成签到,获得积分10
3秒前
啦啦啦123发布了新的文献求助10
3秒前
科目三应助cxt采纳,获得10
5秒前
无花果应助两面性采纳,获得10
5秒前
5秒前
6秒前
英俊的铭应助风中听枫采纳,获得10
8秒前
8秒前
9秒前
Akim应助叶白山采纳,获得10
9秒前
10秒前
ywpzdnb完成签到,获得积分10
11秒前
12秒前
13秒前
jie发布了新的文献求助10
13秒前
14秒前
yuyu发布了新的文献求助10
15秒前
快乐再出发完成签到,获得积分10
15秒前
斯文败类应助Brill采纳,获得10
15秒前
yy完成签到,获得积分10
17秒前
舒适仰发布了新的文献求助30
17秒前
17秒前
ding应助德德采纳,获得10
17秒前
18秒前
ywpzdnb发布了新的文献求助10
18秒前
李爱国应助张英俊采纳,获得10
18秒前
所所应助。。采纳,获得10
18秒前
风中听枫发布了新的文献求助10
20秒前
豌豆完成签到,获得积分10
22秒前
yuyu完成签到,获得积分10
23秒前
啦啦啦123完成签到,获得积分10
23秒前
23秒前
一桶雪碧完成签到,获得积分10
25秒前
Eureka.com完成签到,获得积分10
26秒前
充电宝应助落后幼晴采纳,获得10
26秒前
chloe发布了新的文献求助10
26秒前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
Diagnostic immunohistochemistry : theranostic and genomic applications 6th Edition 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3149204
求助须知:如何正确求助?哪些是违规求助? 2800294
关于积分的说明 7839427
捐赠科研通 2457845
什么是DOI,文献DOI怎么找? 1308138
科研通“疑难数据库(出版商)”最低求助积分说明 628436
版权声明 601706